Reboot Rx Inc Reboot Rx is transforming cancer care by using proprietary AI technology to repurpose generic drugs into affordable and effective treatments.
Reboot Rx Inc has received 10 grants from 5 known foundation funders. Revenue decreased from $2,702,361 in 2023 to $1,047,549 in 2024. Most recent reported revenue: $1,047,549.
Annual Revenue
$1,047,549
Known Funders
5
Grants Received
10
Financial History
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2024 | $1,047,549 | $1,455,986 | $2,202,529 |
| 2023 | $2,702,361 | $974,789 | $2,559,533 |
| 2022 | $520,612 | $591,050 | $982,557 |
| 2021 | $294,776 | $461,492 | $872,303 |
| 2020 | $226,675 | $515,387 | $1,038,010 |
| 2019 | $1,354,675 | $32,070 | $1,323,965 |
Top Funders
HOUSTON, TX
HOUSTON, TX
HOUSTON, TX
DENVER, CO
MENLO PARK, CA
WELLESLEY, MA
WELLESLEY, MA
DENVER, CO
DENVER, CO
Wilmington, DE
Key Personnel
From 2024 IRS 990 filing
David Noymer
Treasurer
Andrea Pollinger
Board Chair and Clerk
Ruchika Kumar
Director
Lara Metcalf
Director
Robert Pozen
Director
Mason Irving III
Director
Sherif Botros
VP of Data Science
Laura Kleiman
President CEO and Director
Frequently Asked Questions
Other Nonprofits in Massachusetts
Unlock Full Nonprofit Data
Sign up for free to access the complete funder list, financial history, program details, key personnel, and smart matching.